NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Dementia


Return to Library

Free Dementia Articles


Research on macular degeneration detailed by B.W. Rovner and co-authors



2009 AUG 3 - (NewsRx.com) -- "The measurement of affective symptoms in older persons who decline cognitively is uncertain. The authors investigated whether mood variability predicts dementia in patients with age-related macular degeneration (AMD)," investigators in the United States report.

"Three-year observational study after a clinical trial. Community follow-up of outpatients ascertained from retina clinics. One hundred sixty patients with AMD. Geriatric Depression Scale (GDS) administered every 2 weeks for 6 months to subjects; Informant Questionnaire for Cognitive Decline in the Elderly (IQCODE) administered to subjects' knowledgeable informants. Twenty-three subjects (14.4%) declined cognitively. Age, education, baseline GDS score >= 5, and variability in GDS scores (i.e., fluctuations between adjacent time points) were associated with cognitive decline. For GDS variability, each 1 unit increase in the residual standard deviation (SD) of the GDS increased the risk for cognitive decline by 93% (IDR = 1.92; 95% CI [1.27-2.91]). Thus, subjects with a residual SD of 1 were nearly twice as likely to become demented as subjects with no variability in GDS scores. The risk for subjects with SDs of 2 increased more than threefold (IDR = 3.68; 95% CI [1.61-8.47]). A multiple regression analysis showed that GDS variability was a significant risk factor for dementia after controlling for significant covariates. These data suggest a useful approach to conceptualizing and measuring depressive symptoms in older persons," wrote B.W. Rovner and colleagues.

The researchers concluded: "Variability in self-reported mood may be an early sign of dementia and may offer new insights into the neurobiological mechanisms linking depression and cognition. (Am J Geriatr Psychiatry 2009; 17:574-581)."

Rovner and colleagues published their study in American Journal of Geriatric Psychiatry (Variability in Depressive Symptoms Predicts Cognitive Decline in Age-Related Macular Degeneration. American Journal of Geriatric Psychiatry, 2009;17(7):574-581).

For additional information, contact B.W. Rovner, Jefferson Hospital Neuroscience, 900 Walnut St., 4th Floor, Philadelphia, PA 19107, USA.

The publisher of the American Journal of Geriatric Psychiatry can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St., Philadelphia, PA 19106-3621, USA.

Keywords: United States, Philadelphia, Age-Related Macular Degeneration, Central Nervous System Disease, Clinical Trial Research, Dementia, Depression, Geriatric Psychiatry, Macular Degeneration, Mental Health.

This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & Central Nervous System Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login